DexCom's Cash Flow King

DexComs strong free cash flow margin of 23.1% sets it apart, while Energy Recovery and LifeStance Health Group face challenges. Energy Recoverys slow revenue growth and projected sales drop, along with fading returns on capital, pose risks. LifeStances lack of scale and growth-driven decline in returns on capital limit cash for reinvestment. DexComs organic revenue growth and supercharged earnings per share, coupled with a significant cash margin increase, make it the smart choice. Valuations range from 16 to 25 times forward P/E, with smart money favoring DexComs momentum. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ee17823ae4708c07